NYSE:MYOV
Delisted
Myovant Sciences Ltd Stock News
$26.98
+0 (+0%)
At Close: Jun 08, 2023
Amia Capital LLP Invests $830,000 in Myovant Sciences Ltd (NYSE:MYOV)
09:44am, Wednesday, 11'th Mar 2020
Amia Capital LLP acquired a new position in shares of Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The i
Bristol-Myers Squibb's Multiple Myeloma Setback, And Other News: The Good, Bad And Ugly Of Biopharma
04:32pm, Tuesday, 10'th Mar 2020
Xenon pharma reported financial results. Myovant moves forward with relugolix. BMY suffers a setback with its MM drug.
BRIEF-Myovant Sciences Cancels Presentation At The Barclays Global Healthcare Conference 2020
01:11pm, Tuesday, 10'th Mar 2020
Myovant Sciences Ltd:
Myovant Sciences Announces Cancellation of Presentation and Webcast at the Barclays Global Healthcare Conference 2020
12:30pm, Tuesday, 10'th Mar 2020
BASEL, Switzerland, March 10, 2020 -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer,.
Myovant Sciences Ltd:
Myovant Sciences files application in Europe for relugolix combo tablet
01:16pm, Monday, 09'th Mar 2020
Myovant Sciences (NYSE:MYOV) has submitted a marketing application in Europe seeking approval to use a combination tablet formulation of relugolix (relugolix 40 mg, estradiol 1.0 mg, and norethindrone
Myovant Sciences submits MAA to EMA for relugolix combination tablet MYOV
01:08pm, Monday, 09'th Mar 2020
Myovant Sciences submits MAA to EMA for relugolix combination tablet MYOV
Myovant Sciences (MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer, today announced the submission of a Marketing Authorization Applicatio
Quantitative Systematic Strategies LLC Acquires Shares of 13,813 Myovant Sciences Ltd (NYSE:MYOV)
10:30am, Sunday, 08'th Mar 2020
Quantitative Systematic Strategies LLC acquired a new stake in Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 13,813 shares of the company’s s
California Public Employees Retirement System Invests $1.06 Million in Myovant Sciences Ltd (NYSE:MYOV)
10:38am, Thursday, 27'th Feb 2020
California Public Employees Retirement System bought a new stake in Myovant Sciences Ltd (NYSE:MYOV) in the fourth quarter, according to the company in its most recent 13F filing with the Securities a
Myovant Sciences to Present at Upcoming March Investor Conferences
01:30pm, Tuesday, 25'th Feb 2020
BASEL, Switzerland, Feb. 25, 2020 -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on developing innovative treatments for women's health and prostate cancer,.
Is the Options Market Predicting a Spike in Myovant (MYOV) Stock?
01:31pm, Friday, 21'st Feb 2020
Investors need to pay close attention to Myovant (MYOV) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Myovant (MYOV) Stock?
01:31pm, Friday, 21'st Feb 2020
Investors need to pay close attention to Myovant (MYOV) stock based on the movements in the options market lately.
Hercules Capital Reports Fourth Quarter and Record Full-Year 2019 Financial Results
09:10pm, Thursday, 20'th Feb 2020
Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of
Myovant Sciences (NYSE:MYOV) Announces Earnings Results, Misses Estimates By $0.16 EPS
12:42pm, Wednesday, 12'th Feb 2020
Myovant Sciences (NYSE:MYOV) posted its quarterly earnings results on Monday. The company reported ($0.96) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($0.16), Bloomberg
